Paper · 8970949
Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.
Karupiah G and 4 others. J Virol, 1996. Cited by 140 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. Papers, record 8970949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8970949
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4-Positive T-Lymphocytes | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Ectromelia virus | Major topic |
| Ectromelia, Infectious | Major topic |
| Macrophages | Major topic |
| Animals | |
| Cell Line | |
| Chlorocebus aethiops | |
| Cytotoxicity, Immunologic | |
| Female | |
| Flow Cytometry | |
| Mice | |
| Mice, Inbred C57BL | |
| Spleen | |
| Virus Replication | |
| beta 2-Microglobulin |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2,295,796 | Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. | J Immunol | 1990 | https://conductscience.org/library/papers/2295796 | PubMed |
| 2 | 14,422,711 | The response of mice to large intravenous injections of ectromelia virus. I. The fate of injected virus. | Br J Exp Pathol | 1959 | https://conductscience.org/library/papers/14422711 | PubMed |
| 3 | 1,546,448 | Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene. | Virology | 1992 | https://conductscience.org/library/papers/1546448 | PubMed |
| 4 | 1,631,092 | Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1631092 | PubMed |
| 5 | 8,083,541 | Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. | J Immunol Methods | 1994 | https://conductscience.org/library/papers/8083541 | PubMed |
| 6 | 212,503 | Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. | J Exp Med | 1978 | https://conductscience.org/library/papers/212503 | PubMed |
| 7 | 2,822,845 | A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice. | J Gen Virol | 1987 | https://conductscience.org/library/papers/2822845 | PubMed |
| 8 | 7,966,595 | CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. | J Virol | 1994 | https://conductscience.org/library/papers/7966595 | PubMed |
| 9 | 8,539,616 | Immunology taught by viruses. | Science | 1996 | https://conductscience.org/library/papers/8539616 | PubMed |
| 10 | 7,690,156 | Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. | Science | 1993 | https://conductscience.org/library/papers/7690156 | PubMed |
1 to 10 of 53
See all 53 referencesCited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,432,776 | Virtual memory CD8⁺ T cells in aging: heterogeneity, bystander protection, inflammatory potential, and inhibitory regulation. | Immun Ageing | 2026 | https://conductscience.org/library/papers/42432776 | PubMed |
| 41,660,658 | Persistent Immunity From Historic Smallpox Vaccination and Its Limited Cross-Neutralization of Monkeypox Virus: A Population-based Serological Study in Taiwan. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/41660658 | PubMed |
| 39,813,296 | MmuPV1 infection of Tmc6/Ever1 or Tmc8/Ever2 deficient FVB mice as a model of βHPV in typical epidermodysplasia verruciformis. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/39813296 | PubMed |
| 39,203,972 | A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39203972 | PubMed |
| 36,553,622 | Genetic Variants and Protective Immunity against SARS-CoV-2. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36553622 | PubMed |
| 35,679,859 | Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses. | Cancer Cell | 2022 | https://conductscience.org/library/papers/35679859 | PubMed |
| 34,107,993 | Zoonotic vaccinia virus strains belonging to different genetic clades exhibit immunomodulation abilities that are proportional to their virulence. | Virol J | 2021 | https://conductscience.org/library/papers/34107993 | PubMed |
| 34,015,056 | Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/34015056 | PubMed |
| 33,113,212 | COVID-19, varying genetic resistance to viral disease and immune tolerance checkpoints. | Immunol Cell Biol | 2021 | https://conductscience.org/library/papers/33113212 | PubMed |
| 33,046,647 | Poxvirus-encoded TNF receptor homolog dampens inflammation and protects from uncontrolled lung pathology during respiratory infection. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/33046647 | PubMed |
1 to 10 of 86
See all 86 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8970949
GET https://conductscience.org/api/papers/v1/8970949/references?page=2